Schottky Barrier-Based Built-In Electric Field for Enhanced Tumor Photodynamic Therapy

ACS Appl Mater Interfaces. 2024 Apr 3;16(13):15916-15930. doi: 10.1021/acsami.4c00018. Epub 2024 Feb 28.

Abstract

Photodynamic therapy's antitumor efficacy is hindered by the inefficient generation of reactive oxygen species (ROS) due to the photogenerated electron-hole pairs recombination of photosensitizers (PS). Therefore, there is an urgent need to develop efficient PSs with enhanced carrier dynamics. Herein, we designed Schottky junctions composed of cobalt tetroxide and palladium nanocubes (Co3O4@Pd) with a built-in electric field as effective PS. The built-in electric field enhanced photogenerated charge separation and migration, resulting in the generation of abundant electron-hole pairs and allowing effective production of ROS. Thanks to the built-in electric field, the photocurrent intensity and carrier lifetime of Co3O4@Pd were approximately 2 and 3 times those of Co3O4, respectively. Besides, the signal intensity of hydroxyl radical and singlet oxygen increased to 253.4% and 135.9%, respectively. Moreover, the localized surface plasmon resonance effect of Pd also enhanced the photothermal conversion efficiency of Co3O4@Pd to 40.50%. In vitro cellular level and in vivo xenograft model evaluations demonstrated that Co3O4@Pd could generate large amounts of ROS, trigger apoptosis, and inhibit tumor growth under near-infrared laser irradiation. Generally, this study reveals the contribution of the built-in electric field to improving photodynamic performance and provides new ideas for designing efficient inorganic PSs.

Keywords: Schottky barrier; built-in electric field; cancer therapy; photodynamic; photothermal.

MeSH terms

  • Cobalt*
  • Humans
  • Infrared Rays
  • Neoplasms* / drug therapy
  • Oxides*
  • Photochemotherapy*
  • Photosensitizing Agents / pharmacology
  • Reactive Oxygen Species

Substances

  • cobalt tetraoxide
  • Reactive Oxygen Species
  • Photosensitizing Agents
  • Cobalt
  • Oxides